News
Mid Cap Specialty chemical stock gained more than 8% during the intraday trades on Friday post Q4 results and Dividend ...
The U.S. market is currently experiencing heightened volatility, with major indices like the Dow Jones and Nasdaq Composite facing declines due to renewed trade tensions following President Trump's ...
Trump threatens Apple with a 25% tariff unless it manufactures iPhones in the US, raising major cost and supply chain ...
Goldman Sachs BDC is offering a high NII yield and trading significantly below NAV. Find out why it's still a Buy for passive ...
5h
Zacks Investment Research on MSN3 Stocks Targeting Weight Loss Market With Cannabinoid-Based TherapiesThe obesity market has garnered much interest lately, propelled by the success of GLP-1 therapies Wegovy and Zepbound, marketed by pharma giants Novo Nordisk NVO and Eli Lilly LLY, respectively. This ...
Equity markets open positively, Nifty and Sensex rise, IT and consumer stocks lead gains, global cues favorable.
Reliance Infrastructure, Afcons and Narayana Hrudayalaya will be among 202 companies to post earnings reports for the January ...
Sanofi has agreed to acquire Vigil Neuroscience in a $470m deal, nearly a year after investing an initial $40m in the company ...
London-based FTSE Russell will remove Indian firm STL Networks Ltd. from the FTSE Global Small Cap Index for failing to list ...
The benchmark equity indices ended on a weaker note on Thursday, May 22, 2025, dragged down by broad-based selling across ...
At around 12:51 pm, the BSE Sensex was down 966.37 points at 80,630.26, while the NSE Nifty50 slumped 269 points to 24,544.45. Market volatility spiked, dragging down broader indices and putting ...
Ozempic made headlines. Now its maker faces stock crashes, CEO fallout, and fierce rivalry from Eli Lilly. Discover the trade behind the drama.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results